Literature DB >> 10580402

Effect of long-term infection with nef-defective attenuated HIV type 1 on CD4+ and CD8+ T lymphocytes: increased CD45RO+CD4+ T lymphocytes and limited activation of CD8+ T lymphocytes.

J J Zaunders1, A F Geczy, W B Dyer, L B McIntyre, M A Cooley, L J Ashton, C H Raynes-Greenow, J Learmont, D A Cooper, J S Sullivan.   

Abstract

Members of the Sydney Blood Bank Cohort (SBBC) have been infected with an attenuated strain of HIV-1 with a natural nef/LTR mutation and have maintained relatively stable CD4+ T lymphocyte counts for 14-18 years. Flow cytometric analysis was used to examine the phenotype of CD4+ and CD8+ T lymphocytes in these subjects, including the immunologically important naive (CD45RA+CD62L+), primed (CD45RO+), and activated (CD38+HLA-DR+ and CD28-) subsets. The median values were compared between the SBBC and control groups, comprising age-, sex-, and transfusion-matched HIV-1-uninfected subjects; transfusion-acquired HIV-1-positive LTNPs; and sexually acquired HIV-1-positive LTNPs. Members of the SBBC not only had normal levels of naive CD4+ and CD8+ T lymphocytes, but had primed CD45RO+ CD4+ T lymphocytes at or above normal levels. Furthermore, these primed cells expressed markers suggesting recent exposure to specific antigen. SBBC members exhibited variable activation of CD8+ T lymphocytes. In particular, SBBC members with undetectable plasma HIV-1 RNA had normal levels of activated CD8+ T lymphocytes. Therefore, the result of long-term infection with natural nef/LTR mutant HIV-1 in these subjects suggests a decreased cytopathic effect of attenuated HIV-1 on susceptible activated CD4+ T lymphocyte subsets in vivo, and minimal activation of CD8+ T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10580402     DOI: 10.1089/088922299309801

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  13 in total

1.  Comprehensive analysis of unique cases with extraordinary control over HIV replication.

Authors:  Daniel Mendoza; Sarah A Johnson; Bennett A Peterson; Ven Natarajan; Maria Salgado; Robin L Dewar; Peter D Burbelo; Nicole A Doria-Rose; Erin H Graf; Jamieson H Greenwald; Jessica N Hodge; William L Thompson; Nancy A Cogliano; Cheryl L Chairez; Catherine A Rehm; Sara Jones; Claire W Hallahan; Joseph A Kovacs; Irini Sereti; Omar Sued; Sheila A Peel; Robert J O'Connell; Una O'Doherty; Tae-Wook Chun; Mark Connors; Stephen A Migueles
Journal:  Blood       Date:  2012-04-05       Impact factor: 22.113

2.  Impaired Downregulation of NKG2D Ligands by Nef Proteins from Elite Controllers Sensitizes HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.

Authors:  Nirmin Alsahafi; Jonathan Richard; Jérémie Prévost; Mathieu Coutu; Nathalie Brassard; Matthew S Parsons; Daniel E Kaufmann; Mark Brockman; Andrés Finzi
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

3.  Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity.

Authors:  Nirmin Alsahafi; Shilei Ding; Jonathan Richard; Tristan Markle; Nathalie Brassard; Bruce Walker; George K Lewis; Daniel E Kaufmann; Mark A Brockman; Andrés Finzi
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

4.  Lentivirus Nef specifically activates Pak2.

Authors:  V K Arora; R P Molina; J L Foster; J L Blakemore; J Chernoff; B L Fredericksen; J V Garcia
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Impaired Nef function is associated with early control of HIV-1 viremia.

Authors:  Xiaomei T Kuang; Xiaoguang Li; Gursev Anmole; Philip Mwimanzi; Aniqa Shahid; Anh Q Le; Louise Chong; Hua Qian; Toshiyuki Miura; Tristan Markle; Bemuluyigza Baraki; Elizabeth Connick; Eric S Daar; Heiko Jessen; Anthony D Kelleher; Susan Little; Martin Markowitz; Florencia Pereyra; Eric S Rosenberg; Bruce D Walker; Takamasa Ueno; Zabrina L Brumme; Mark A Brockman
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

6.  Lipid metabolism in patients infected with Nef-deficient HIV-1 strain.

Authors:  Hann Low; Lesley Cheng; Maria-Silvana Di Yacovo; Melissa J Churchill; Peter Meikle; Michael Bukrinsky; Andrew F Hill; Dmitri Sviridov
Journal:  Atherosclerosis       Date:  2015-10-30       Impact factor: 5.162

7.  Attenuation of multiple Nef functions in HIV-1 elite controllers.

Authors:  Philip Mwimanzi; Tristan J Markle; Eric Martin; Yoko Ogata; Xiaomei T Kuang; Michiyo Tokunaga; Macdonald Mahiti; Florencia Pereyra; Toshiyuki Miura; Bruce D Walker; Zabrina L Brumme; Mark A Brockman; Takamasa Ueno
Journal:  Retrovirology       Date:  2013-01-07       Impact factor: 4.602

8.  Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease.

Authors:  John Zaunders; David van Bockel
Journal:  Front Immunol       Date:  2013-04-24       Impact factor: 7.561

9.  Antibody microarray analysis of cell surface antigens on CD4+ and CD8+ T cells from HIV+ individuals correlates with disease stages.

Authors:  Jing Qin Wu; Bin Wang; Larissa Belov; Jeremy Chrisp; Jenny Learmont; Wayne B Dyer; John Zaunders; Anthony L Cunningham; Dominic E Dwyer; Nitin K Saksena
Journal:  Retrovirology       Date:  2007-11-26       Impact factor: 4.602

10.  Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.

Authors:  Paul R Gorry; Dale A McPhee; Erin Verity; Wayne B Dyer; Steven L Wesselingh; Jennifer Learmont; John S Sullivan; Michael Roche; John J Zaunders; Dana Gabuzda; Suzanne M Crowe; John Mills; Sharon R Lewin; Bruce J Brew; Anthony L Cunningham; Melissa J Churchill
Journal:  Retrovirology       Date:  2007-09-23       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.